Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials

BACKGROUND AND OBJECTIVE: Studies examining the prognostic value of the BRAF mutation on relapse-free survival (RFS), disease-free survival (DFS) and overall survival (OS) in stage II/III colorectal cancer (CRC) patients receiving curative resection and adjuvant chemotherapy so far showed discrepant...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lizhen, Dong, Caixia, Cao, Ying, Fang, Xuefeng, Zhong, Chenhan, Li, Dan, Yuan, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854379/
https://www.ncbi.nlm.nih.gov/pubmed/27138801
http://dx.doi.org/10.1371/journal.pone.0154795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854379/
https://www.ncbi.nlm.nih.gov/pubmed/27138801
http://dx.doi.org/10.1371/journal.pone.0154795

Ejemplares similares